Sep 2026· Eurasian Journal of Medicine and Oncology· 0 citations
TL;DR
The gut microbiome, immune, and antioxidant (GIA) axis is introduced as a unifying, systems-level conceptual framework to explain treatment heterogeneity and optimize cancer immunotherapy outcomes to overcome therapeutic resistance and transition host-microbiome-immune integration from conceptual promise to clinical reality.
Abstract
Introduction: The gut microbiome, host redox homeostasis, and immune regulation are mechanistically interdependent. However, their integrated role in driving resistance to immune checkpoint inhibitors remains incompletely defined.Objective: This review introduces the gut microbiome, immune, and antioxidant (GIA) axis as a unifying, systems-level conceptual framework to explain treatment heterogeneity and optimize cancer immunotherapy outcomes.Scope: We synthesize current mechanistic and translational evidence linking microbiota-derived metabolites, including short-chain fatty acids, bile acids, and tryptophan derivatives, to oxidative stress responses, mitochondrial fitness, and anti-tumor immune competence across colorectal, hepatobiliary, and neuro-oncologic malignancies.Key findings: Disruption of the GIA network promotes immunotherapy resistance through excessive oxidative burden, pathological Nrf2 signaling, and the expansion of immunosuppressive myeloid populations. Conversely, targeted microbiome interventions, including probiotics, postbiotics, and fecal microbiota transplantation, can successfully restore redox-immune equilibrium, remodel the tumor microenvironment, and enhance the efficacy of checkpoint blockade.Conclusion: We propose a precision immuno-oncology framework utilizing composite GIA-axis biomarker profiling for patient stratification. Integrating these multidisciplinary insights identifies actionable translational opportunities to overcome therapeutic resistance and transition host-microbiome-immune integration from conceptual promise to clinical reality.
The crosstalk between the gut microbiota and the host redox system is essential for maintaining intestinal homeostasis and systemic health. Disruption of this bidirectional interaction impairs redox balance, promotes oxidative stress, and contributes to the initiation and progression of a wide range of diseases, includ...
Shuai-Hu Chen, Yu-Long Yin, Jie Yin et al.· Antioxidants· 0 citations
ABSTRACT The gut microbiota–tryptophan (TRP) metabolism–immune axis is one of the core pathogenic mechanisms in inflammatory bowel disease (IBD). Physiologically, gut microbes convert dietary TRP into bioactive metabolites that regulate intestinal immune balance and barrier function via AHR. In IBD, this axis enters a...
The mammalian immune system has evolved in constant dialogue with its diverse microbiota, forming an ecological and molecular partnership that is fundamental to health. This review examines how microbial communities shape immunity across developmental and functional axes, the immunological consequences of dysbiosis dur...
P. Babu, V. Prakash, Suja Subhash et al.· Frontiers in Cellular and In...· 0 citations
Introduction Immune checkpoint inhibitors (ICIs) have transformed the management of microsatellite instability-high/deficient mismatch repair (MSI-H/dMMR) colorectal cancer (CRC). However, a substantial proportion of patients exhibit primary resistance or eventually develop acquired resistance, highlighting the need fo...
Marko Marjanovic, Nemanja Maletin, B. Kukic et al.· Frontiers in Cellular and In...· 0 citations
Cancer remains a major global health challenge, and growing evidence indicates that the gut microbiota plays an important role in cancer initiation, progression, metastasis, and response to treatment through complex interactions with host signaling, metabolism, and immunity. This comprehensive narrative review discusse...
P. Negi, Arpita Upreti, Preeti Budhlakoti et al.· Frontiers in Molecular Biosc...· 0 citations
Here, we summarize available data on mechanisms by which the gut microbiota may affect immune checkpoint inhibitors (ICIs) and discuss potential therapeutic approaches targeting the microbiota. Gut microbiota could affect both antitumor immunity and immune-related toxicities through orchestration of the mucosal and sys...
Yusa Xie· Theoretical and Natural Scie...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.